News

Thermo Fisher Scientific said that the MetQuest software is designed to provide researchers performing drug metabolism and pharmacokinetic (DMPK) studies time and cost savings when compared to traditional

John Bell & Croyden said that the Healthpoint system delivers information on over 3000 health topics. All the information is medically referenced and is presented in a format

Aspen is planning to acquire Sigma either directly or through a wholly-owned subsidiary. The amount set by Aspen includes A$707m in issued shares and A$785m in net debt,

In the study, cell lines derived from mesothelioma patients were found not to express miR-31, a microRNA that has recently been characterized as a suppressor of breast cancer

Ranbaxy Pharmaceuticals Canada said that RAN-Atorvastatin is expected to be made available to all Canadian patients under the Ranbaxy label, subject to provincial formulary listings. Atorvastatin is an

Ortho-McNeil Pharmaceutical is said to have been used promotional program called the ‘Doctor for a Day Program’ to promote its epilepsy drug, Topamax to psychiatrists, including some in

Shire stated that the FDA approved Intuniv on September 2, 2009 as an ADHD treatment for children and adolescents ages 6 to 17, based on two pivotal monotherapy

LUX-Lung 2 is part of the comprehensive LUX-Lung clinical trial programme. Currently, the clinical trial programme comprises more than ten trials conducted across the globe. LUX-Lung 2 is

Shimadzu and bioMerieux have said that the new solution is planned for commercialisation by bioMerieux in 2010, together with the microbial database acquired from AnagnosTec. Shimadzu has developed